FUMAGALLI, CARLO
 Distribuzione geografica
Continente #
EU - Europa 5.394
NA - Nord America 1.801
AS - Asia 500
AF - Africa 14
SA - Sud America 9
OC - Oceania 2
Totale 7.720
Nazione #
IT - Italia 3.852
US - Stati Uniti d'America 1.797
RU - Federazione Russa 841
IE - Irlanda 208
SE - Svezia 156
SG - Singapore 146
HK - Hong Kong 134
CN - Cina 99
CH - Svizzera 75
PL - Polonia 64
JO - Giordania 45
NL - Olanda 45
DE - Germania 38
GB - Regno Unito 36
IN - India 36
FR - Francia 18
KR - Corea 15
FI - Finlandia 12
ES - Italia 9
DK - Danimarca 8
TR - Turchia 7
BR - Brasile 6
CI - Costa d'Avorio 6
BE - Belgio 5
RS - Serbia 5
UA - Ucraina 5
VN - Vietnam 5
CA - Canada 3
GH - Ghana 3
IR - Iran 3
TH - Thailandia 3
AU - Australia 2
BY - Bielorussia 2
EC - Ecuador 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
LT - Lituania 2
LY - Libia 2
MG - Madagascar 2
MM - Myanmar 2
MT - Malta 2
RO - Romania 2
SA - Arabia Saudita 2
BG - Bulgaria 1
CO - Colombia 1
CZ - Repubblica Ceca 1
JP - Giappone 1
MK - Macedonia 1
MX - Messico 1
NO - Norvegia 1
PT - Portogallo 1
TN - Tunisia 1
Totale 7.720
Città #
Santa Clara 594
Milan 400
Rome 305
Dublin 203
Florence 144
Chandler 136
Ashburn 132
Singapore 128
Fairfield 118
Hong Kong 96
Turin 93
Naples 80
Bologna 74
Moscow 60
Lawrence 58
Warsaw 58
Altamura 57
Genoa 52
Bari 45
Woodbridge 41
Wilmington 40
Cambridge 39
Padova 38
Seattle 37
Houston 35
Princeton 35
Palermo 34
Boston 31
Shanghai 29
Bern 27
Verona 27
New York 26
Mumbai 25
Modena 22
Beijing 21
Buffalo 21
Venice 20
Munich 19
San Diego 18
Ann Arbor 17
Livorno 17
Brescia 16
Zurich 16
Perugia 15
Seoul 15
Cagliari 13
Monza 13
Parma 13
Prato 13
Grottaglie 12
West Jordan 12
Bergamo 11
Rimini 11
Catania 10
Kent 10
Reggio Emilia 10
Trento 10
Trieste 10
Hillsboro 9
Medford 9
Messina 9
Washington 9
Copenhagen 8
Ancona 7
Barcelona 7
Cantù 7
Helsinki 7
Latina 7
Los Angeles 7
Lucca 7
Montesilvano Marina 7
Pune 7
Rifredi 7
Valsamoggia 7
Verdellino 7
Voghera 7
Abidjan 6
Arosio 6
Ascoli Piceno 6
Boardman 6
Bolzano 6
Bronte 6
Ciserano 6
Cologno Monzese 6
Fermo 6
Giano dell'Umbria 6
Imola 6
London 6
Musile di Piave 6
Osio Sotto 6
Pisa 6
Taranto 6
Treviso 6
Villafranca in Lunigiana 6
Azzano San Paolo 5
Belgrade 5
Cinisello Balsamo 5
Corridonia 5
Giugliano in Campania 5
Macerata 5
Totale 3.935
Nome #
Ascolto di musica a 440 HZ versus musica a 432 HZ per la riduzione dell’ansia covid correlata negli infermieri del 118: un trial pilota randomizzato controllato in doppio cieco 3.803
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 133
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study 125
Association of Obesity with Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy 112
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 109
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 107
LA TERAPIA ANTICOAGULANTE ORALE IN PAZIENTI DI ETÀ AVANZATA CON FIBRILLAZIONE ATRIALE È ANCORA POCO UTILIZZATA. UN’ANALISI DEL REGISTRO GEROCOVID DELLA SOCIETÀ ITALIANA DI GERONTOLOGIA E GERIATRIA 102
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 99
Correction to: Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy (Journal of Nuclear Cardiology, (2022), 10.1007/s12350-022-02911-y) 99
Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): a pilot study 96
Biometric refractive error after cataract and retina surgery: a systematic review and a benchmark proposal 95
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 94
Cardiomyopathies in children – inherited heart muscle disease: Overview of hypertrophic, dilated, restrictive and non-compaction phenotypes 90
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 89
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 86
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 84
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening 84
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 82
P2316Outcome of septal reduction therapies for obstructive hypertrophic cardiomyopathy in a high-flow referral centre with moderate volume procedural programmes 81
Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy 79
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 79
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 79
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 78
Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy 77
EFFETTI DELLA TERAPIA PRE-RICOVERO CON ANTAGONISTI DEL SISTEMA RENINA-ANGIOTENSINA IN PAZIENTI DI ETÀ AVANZATA CON COVID-19. DAL REGISTRO GEROCOVID DELLA SOCIETÀ ITALIANA DI GERONTOLOGIA E GERIATRIA 77
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 77
Feasibility of a combined mobile-health electrocardiographic and rapid diagnostic test screening for chagas-related cardiac alterations 75
Atrial fibrillation and COVID-19 in older patients: how disability contributes to shape the risk profile. An analysis of the GeroCovid registry 74
Ranolazine is associated with a reduced incidence of atrial fibrillation in patients with chronic coronary syndrome: the results of a real-world analysis of an Italian population 73
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 73
Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy 70
The Listening to music tuned to 440 Hz versus 432 Hz to reduce anxiety and stress in emergency nurses during the COVID-19 pandemic: a double-blind, randomized controlled pilot study 69
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 67
Ventricular arterial coupling alteration and long term prognosis in patients with hypertrophic cardiomyopathy 65
The Importance of Sex Differences in Patients with Hypertrophic Cardiomyopathy – Tailoring Management and Future Perspectives 64
β-blockers: Their new life from hypertension to cancer and migraine 63
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis 62
Lower extremity performance predicts length of hospital stay in older candidates to elective cardiac surgery 61
Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre 60
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities? 60
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 57
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 54
P392Preliminary evaluation of stress myocardial blood flow pattern in patients with apical hypertrophic cardiomyopathy candidate to be enrolled in the CARAPACE study 54
Telemedicine cardiovascular screening program in low-income settings by smartphone based technology 53
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 53
Low incidence of arrhythmic syncope and pacemaker implantation in older patients with bifascicular block and implantable cardiac monitor 52
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease 51
Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation 49
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 47
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 46
Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist 46
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 45
Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis 41
From atrial fibrillation management to atrial myopathy assessment: the evolving concept of left atrium disease in hypertrophic cardiomyopathy 37
International patient preferences for physician attire: results from cross-sectional studies in four countries across three continents 33
Layman electrocardiographic screening using smartphone-based multiple‑lead ECG device in school children 24
null 7
Totale 7.801
Categoria #
all - tutte 20.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020160 0 0 0 0 5 13 36 32 27 11 24 12
2020/2021216 12 17 14 41 15 6 22 21 23 24 11 10
2021/2022289 22 6 11 9 15 17 6 23 35 21 52 72
2022/2023898 56 180 51 39 61 152 124 59 99 7 36 34
2023/20241.603 28 52 72 29 62 92 47 147 53 226 359 436
2024/20254.635 1.019 691 614 1.090 1.221 0 0 0 0 0 0 0
Totale 7.801